Clinical Journal of Gastroenterology

, Volume 11, Issue 4, pp 309–311 | Cite as

Repeated Clostridium difficile infection after living donor liver transplantation

  • Kyohei AbeEmail author
  • Hiroaki Shiba
  • Kenei Furukawa
  • Taro Sakamoto
  • Yuichi Ishida
  • Katsuhiko Yanaga
Case Report


Liver transplant recipients are considered to be at high risk for Clostridium difficile infection, with an incidence of 2.7–8.0%, which is three times higher than that among other patients. A case of a patient who suffered from pseudomembranous colitis five times after living donor liver transplantation is reported. A 60-year-old woman underwent splenectomy and living donor liver transplantation using the left lobe of her spouse for primary biliary cirrhosis. The patient made a satisfactory recovery, except for splenic vein thrombosis. She was discharged on postoperative day 36; however, she developed pseudomembranous colitis due to Clostridium difficile infection five times within 6 months after transplant and was treated with oral vancomycin each time. At the fifth recurrence of pseudomembranous colitis, the patient received vancomycin taper treatment, dietary counseling, and repeat instructions regarding hand hygiene and house cleaning. The patient recovered and is currently well without recurrence of Clostridium difficile infection 36 months after living donor liver transplantation.


Clostridium difficile Liver transplant recipients Vancomycin taper treatment 


Compliance with ethical standards

Conflict of interest

Kyohei Abe, Hiroaki Shiba, Kenei Furukawa, Taro Sakamoto, Yuichi Ishida, and Katsuhiko Yanaga declare that they have no conflict of interest.

Human rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all patients for being included in the study.


  1. 1.
    Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–80.CrossRefPubMedGoogle Scholar
  2. 2.
    Ali M, Ananthakrishnan AN, Ahmad S. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl. 2012;18:972–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Mittal C, Hassan S, Arshad S, et al. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Am J Transplant. 2014;14:1901–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl. 2005;11:881–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Albright JB, Bonatti H, Mendez J, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int. 2007;20:856–66.CrossRefPubMedGoogle Scholar
  6. 6.
    Hashimoto M, Sugawara Y, Tamura S, et al. Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol. 2007;13:2072–6.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Stelzmueller I, Goegele H, Biebl M, et al. Clostridium difficile colitis in solid organ transplantation—a single-center experience. Dig Dis Sci. 2007;52:3231–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Neff G, Zacharias V, Kaiser TE, et al. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: a case series. Liver Transpl. 2010;16:960–3.CrossRefPubMedGoogle Scholar
  9. 9.
    Rochon C, Kardashian A, Mahadevappa B, et al. Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection. Transplant Proc. 2011;43:3819–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Hsu JL, Enser JJ, McKown T, et al. Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants. Clin Transplant. 2014;28:267–73.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle:treatment strategies for 163 cases of recurrent. Clostridium difficile disease. Am J Gastroenterol. 2002;97(7):1769–75.CrossRefPubMedGoogle Scholar
  12. 12.
    Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol. 1985;80(11):867–8.PubMedGoogle Scholar
  13. 13.
    Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  • Kyohei Abe
    • 1
    Email author
  • Hiroaki Shiba
    • 1
  • Kenei Furukawa
    • 1
  • Taro Sakamoto
    • 1
  • Yuichi Ishida
    • 1
  • Katsuhiko Yanaga
    • 1
  1. 1.Department of SurgeryThe Jikei University School of MedicineTokyoJapan

Personalised recommendations